Not Tagged
pfizer,novartis
['novartis', 'pfizer']
what we're following at
#asco22: in yet another stinging setback, pfizer s blockbuster cdk 4/6 fails its latest test on survival. but can novartis and eli lilly benefit? 
Founder, EIC of Endpoints News: The biopharma world is here -- 144,000 global industry subscribers. We work for it. #sweatequity john@endpointsnews.com